Eisai
4523.T
#2257
Rank
A$12.23 B
Marketcap
A$43.37
Share price
-1.64%
Change (1 day)
-3.22%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.31. an increase over its 2024 EPS that were of A$1.48.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.6511.85%
2024A$1.48-32.63%
2023A$2.195.52%
2022A$2.08-74.01%
2021A$8.00-66.58%
2020A$23.9298.24%
2019A$12.0717.01%
2018A$10.3137.78%
2017A$7.49-27.62%
2016A$10.3435.33%
2015A$7.64-2.82%
2014A$7.86-27.66%
2013A$10.87-27.49%
2012A$14.99-12.67%
2011A$17.1788.08%
2010A$9.13-11.06%
2009A$10.26-390.15%
2008A-$3.54-127.78%
2007A$12.7411.78%
2006A$11.394.38%
2005A$10.927.4%
2004A$10.1743.03%
2003A$7.1125.09%
2002A$5.6852.67%
2001A$3.7269.76%
2000A$2.19